Literature DB >> 12787523

Arthritis associated with enteric infection.

J S Hill Gaston1, Mark S Lillicrap.   

Abstract

Reactive arthritis is classically seen following infection with enteric pathogens such as Yersinia, Salmonella, Campylobacter and Shigella. Inflammatory arthritis has also been described following other enteric infection with organisms such as Clostridium difficile, Brucella and Giardia. Furthermore, arthritis is seen in Whipple's disease, caused by the actinomycete Tropheryma whippelii. This chapter reviews the current understanding of these conditions (with the exception of Brucella, which is discussed in a subsequent chapter). The epidemiology is reviewed, and the contribution of both host and organism to the aetiology and pathogenesis is discussed with particular discussion of the role of HLA-B27 in host susceptibility. Recent work exploring evidence for traffic of pathogenic organisms to the joint is highlighted. A practical approach to the diagnosis and management of the condition is then formulated based, where possible, on clinical trial evidence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787523     DOI: 10.1016/s1521-6942(02)00104-3

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  36 in total

Review 1.  [Reactive arthritis: from pathogenesis to novel strategies].

Authors:  M Rihl; J G Kuipers
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

2.  Genotyping of human and porcine Yersinia enterocolitica, Yersinia intermedia, and Yersinia bercovieri strains from Switzerland by amplified fragment length polymorphism analysis.

Authors:  Kathrin Kuehni Boghenbor; Stephen L W On; Branko Kokotovic; Andreas Baumgartner; Trudy M Wassenaar; Matthias Wittwer; Beatrice Bissig-Choisat; Joachim Frey
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

Review 3.  Campylobacter reactive arthritis: a systematic review.

Authors:  Janet E Pope; Adriana Krizova; Amit X Garg; Heather Thiessen-Philbrook; Janine M Ouimet
Journal:  Semin Arthritis Rheum       Date:  2007-03-13       Impact factor: 5.532

4.  Clostridium difficile Colitis Leading to Reactive Arthritis: A Rare Complication Associated With a Common Disease.

Authors:  Asghar Marwat; Hassan Mehmood; Ali Hussain; Muzammil Khan; Asad Ullah; Medha Joshi
Journal:  J Investig Med High Impact Case Rep       Date:  2018-03-30

Review 5.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 6.  [Update on reactive arthritis].

Authors:  M Rihl
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

7.  Evaluation of a western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi.

Authors:  Mindy L Rawlins; Cecilia Gerstner; Harry R Hill; Christine M Litwin
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

8.  Establishment of a Shigella sonnei human challenge model in Thailand.

Authors:  Ladaporn Bodhidatta; Punnee Pitisuttithum; Supat Chamnanchanant; Karen T Chang; Dilara Islam; Valai Bussaratid; Malabi M Venkatesan; Thomas L Hale; Carl J Mason
Journal:  Vaccine       Date:  2012-10-12       Impact factor: 3.641

9.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Authors:  John D Carter; Herve C Gerard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2012-12-01

10.  Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis.

Authors:  Mariam Siala; Radhouane Gdoura; Hela Fourati; Markus Rihl; Benoit Jaulhac; Mohamed Younes; Jean Sibilia; Sofien Baklouti; Naceur Bargaoui; Slaheddine Sellami; Abdelghani Sghir; Adnane Hammami
Journal:  Arthritis Res Ther       Date:  2009-07-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.